Etiler Nci Bufe Stock Current Valuation

ETILR Stock  TRY 6.96  0.30  4.13%   
Valuation analysis of Etiler nci Bufe helps investors to measure Etiler Nci's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
6.96
Please note that Etiler Nci's price fluctuation is moderately volatile at this time. Calculation of the real value of Etiler nci Bufe is based on 3 months time horizon. Increasing Etiler Nci's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Etiler Nci is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Etiler Stock. However, Etiler Nci's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  6.96 Real  6.97 Hype  7.26
The intrinsic value of Etiler Nci's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Etiler Nci's stock price.
6.97
Real Value
12.07
Upside
Estimating the potential upside or downside of Etiler nci Bufe helps investors to forecast how Etiler stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Etiler Nci more accurately as focusing exclusively on Etiler Nci's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
2.167.2612.36
Details

Etiler nci Bufe Company Current Valuation Analysis

Etiler Nci's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Etiler Nci Current Valuation

    
  522.3 M  
Most of Etiler Nci's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Etiler nci Bufe is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Etiler nci Bufe has a Current Valuation of 522.3 M. This is 97.11% lower than that of the Hotels, Restaurants & Leisure sector and 94.82% lower than that of the Consumer Discretionary industry. The current valuation for all Turkey stocks is 96.86% higher than that of the company.

Etiler Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Etiler Nci's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Etiler Nci could also be used in its relative valuation, which is a method of valuing Etiler Nci by comparing valuation metrics of similar companies.
Etiler Nci is currently under evaluation in current valuation category among its peers.

Etiler Fundamentals

About Etiler Nci Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Etiler nci Bufe's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Etiler Nci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Etiler nci Bufe based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Etiler Stock

Etiler Nci financial ratios help investors to determine whether Etiler Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Etiler with respect to the benefits of owning Etiler Nci security.